Search Results for epilepsy

News roundup: NeuroPace’s brain study, Welbeing’s Liverpool win, VA’s Apple talks, Medtronic’s diabetes move

NeuroPace, which developed an implanted brain-responsive neuromodulation system for patients with refractory and drug-resistant epilepsy, announced the result of their nine-year long-term treatment study. Approximately 3 out of 4 patients responded to therapy, achieving at least 50% seizure reduction 1 in 3 patients achieved at least 90% seizure reduction 28% of patients experienced seizure-free periods of six months or longer; 18% experienced seizure-free periods of one year or longer Median seizure reduction across all patients was 75% at 9 years Quality of life improvements (including cognition) were sustained through 9 years, with no chronic stimulation-related side effects. The study included... Continue Reading

Independent For Longer website debuts (UK)

The Independent for Longer website has been profiled on the website magazine Ucan2, which highlights mobility aids, assistive technologies, and techniques for better management of a wide variety of disabilities, including learning and autism spectrum. The website showcases real-life TECS (technology enabled care solutions) in the form of seven ‘case studies’ spanning ages from 20 to 79: brain injury, stroke, epilepsy, collapse, ill health, heart failure, and learning difficulties. Each leads the viewer through how a home can be enabled through the selective use of equipment to support independent living. The eighth section is about ‘Billy the Dog’, the Dementia... Continue Reading

‘Neuroprosthetic’ in development to ‘Restore Active Memory’ for PTSD, TBI

...received grants up to $22 million over four years for research on an implantable neuroprosthetic. UCLA’s approach is to focus on the entorhinal area of the brain which researchers previously demonstrated could be stimulated and with the hippocampus is involved in learning and memory. Initial research is testing brain electrodes for epilepsy and to develop a computational model of the hippocampal-entorhinal system. Medtronic is using those models and as the newest partner, evaluating a novel neural stimulation and monitoring system to restore brain memory function. A true neuroprosthetic–consider an assistance chip on or near the brain–is years away. In the... Continue Reading

A mélange of short subjects for Tuesday

...be representative of the whole population [TTA 10 Mar, see 11 Mar update] including us Android users. 9to5Mac….The Google-Novartis glucose-measuring contact lens [TTA 17 July 14] for diabetes management just gained some Canadian competition–Medella Health in Kitchener, Ontario, founded by a team of very young researchers from the University of Waterloo. They believe that their go-to-market prices will be about $25/lens versus $250 from Google. Just so they don’t scratch. HealthTech Insider…Telemedicine consult pilots just announced in Boston and New York. Mount Sinai in NY will be using doctor-patient consults for stroke, primary care, pediatric epilepsy (supporting an upstate health... Continue Reading

More (much more) on tDCS brain stimulation research

...Electrical stimulation is just the beginning The most important application may be clinical treatment CCNY’s Marom Bikson forcefully advocates the last for those with epilepsy, migraine, stroke and depression–and ultimately tDCS may be better than, or work best in conjunction with drug therapy. “The science and early medical trials suggest tDCS can have as large an impact as drugs and specifically treat those who have failed to respond to drugs,” he told me. “tDCS researchers go to work every day knowing the long-term goal is to reduce human suffering on a transformative scale.” What’s not mentioned in any of this... Continue Reading

Sleep monitor for telecare in epilepsy, abnormal night activity

night or designated sleep times, it alerts only for prolonged movement typical of a seizure or other suspect night activity, activating the phone with both audio and video. The movements are also recorded and logged for date/time/duration. It is not inexpensive: the SAMi camera alone is $399 and $949 for the fully configured kit with a iPod plus Wi-Fi router. The new Indiegogo campaign is to raise $90,000 for the next gen camera and to purchase units for charitable distribution to families. Also Medgadget. (A search here on ‘epilepsy’ will confirm the lack of attention to–and the need for–epilepsy monitoring)... Continue Reading

Brain stimulation therapy explored by DARPA

...implants for possible treatment of several chronic neuropsychological conditions. They are seeking to evaluate neural and behavioral processes in PTSD, TBI, major depression, borderline personality disorder, general anxiety disorder, substance abuse/addiction and fibromyalgia/chronic pain through the SUBNETS program (Systems-Based Neurotechnology for Emerging Therapies). All these conditions are on the rise with service members and veterans. DBS is currently used in neurological diseases that impair motor function–Parkinson’s and dystonia–and is being researched for treatment of depression, obsessive compulsive disorder, Tourette’s and epilepsy. SUBNETS is also linked to NIH’s BRAIN Initiative. Armed With Science article, the SUBNETS pre-solicitation (Photo courtesy of DARPA)... Continue Reading

Medtronic confirms forecast direction change, the market reacts, and brains are stimulated

...Benzinga reflecting the consensus in Yahoo Finance). What is interesting are their advances in brain stimulation to relieve pain in two areas. Earlier this month, Medtronic received FDA approval for their RestoreSensor SureScan MRI neurostimulation system, an implant in the spinal cord to treat chronic back pain that also allows the patient to undergo an MRU with the implant in place. Following this was an announcement for the Activa PC+S deep brain stimulation system to record brain activity while delivering electronic therapy to treat Parkinson’s symptoms, essential tremors and epilepsy. It received its CE Mark in January but is still... Continue Reading

Instead of pharmaceuticals, electroceuticals?

...or inhibiting the malfunctioning pathways via tiny electrodes may show a way to health without biological drugs. For instance, stimulating the vagus nerve seems to reduce the production of cytokines — immune system mediators — and blocks inflammation through boosting the immune system. It has been successfully used on a preliminary basis in treating inflammatory disease with rheumatoid arthritis. Multiple research teams have experimented with additional conditions such as respiratory diseases, asthma and diabetes–and possibly neuro-psychiatric disorders like Parkinson’s and epilepsy. It’s been successful enough to date to warrant a small investment from pharma giant Glaxo Smith Kline (GSK). Wired.co.uk... Continue Reading

O2’s mobile care – in a shop near you (UK)

...effective because they have selected a young to late middle age group with various medical problems (epilepsy, cardiac, MS) who are easy to identify with. And the executions strike a different tone than the usual. Benefits are low key but could not be clearer or more convincing--the users are free of fear, restrictions and can enjoy everyday life; their families have their life back. They are refreshingly free of strained, fake-feeling feature/demos and 'horror stories'--alas, I waited in vain for the person down and ambulance vignette. Will the core market identify with this and buy? Definitely carers/families will, but perhaps... Continue Reading